• iPSC-Derived Multilineage Organoids Enable Pan-Genotype HEV

  2026-08-02

  The reference study establishes iPSC-derived liver, intestinal, and brain organoids as robust models supporting the full life cycle of hepatitis E virus (HEV) across major genotypes. This innovation enables detailed investigation of HEV tissue tropism, host-pathogen interactions, and antiviral drug evaluation in physiologically relevant human systems.

• Irinotecan (CPT-11) in Colorectal Cancer: Molecular Pharmaco

  2026-08-01

  Explore the molecular pharmacology and translational applications of Irinotecan (CPT-11) in colorectal cancer research. This in-depth article uniquely dissects DNA damage induction, metabolic activation, and assay design strategies, offering insights beyond standard protocols.

• Precision qPCR for Translational Oncology: From Mechanism to

  2026-07-31

  Explore how HotStart™ 2X Green qPCR Master Mix empowers translational researchers to dissect oncogenic mechanisms like SNORA38B-driven pathways in NSCLC with unprecedented specificity and workflow efficiency. This article bridges mechanistic insight and strategic guidance, highlighting best practices for real-time PCR gene expression analysis in modern translational studies.

• Palmitic acid (Hexadecanoic Acid): Technical Protocol & QC G

  2026-07-31

  Palmitic acid (SKU N2456) offers a high-purity, well-characterized saturated long-chain fatty acid for researchers investigating lipid metabolism pathways, protein palmitoylation, and metabolic disorder models. It is not suitable for aqueous-based protocols or long-term solution storage, making precise reconstitution and prompt use essential for reproducible results.

• 2X Taq PCR Master Mix: Reliable PCR for Genotyping & Cloning

  2026-07-30

  The 2X Taq PCR Master Mix (with dye) transforms routine DNA amplification, offering robust, error-minimized workflows for genotyping and TA cloning. This article dives deep into protocol enhancements, advanced use-cases, and troubleshooting, while connecting innovations in plant viral diagnostics to streamlined PCR assay design.

• ARCA EGFP mRNA (5-moUTP): Deep Dive into Polyadenylated mRNA

  2026-07-30

  Explore ARCA EGFP mRNA (5-moUTP) as an advanced polyadenylated mRNA tool, delivering superior fluorescence-based transfection control with reduced immunogenicity. This article reveals technical mechanisms, practical assay strategies, and insights from leading mRNA delivery research.

• AG-490 (Tyrphostin B42): Applied JAK2/EGFR Inhibition in Can

  2026-07-29

  AG-490 (Tyrphostin B42) empowers precise dissection of JAK2/STAT and MAPK signaling, with particular strength in modeling tumor-immune interactions such as M2 macrophage polarization in hepatocellular carcinoma. Its robust protocol flexibility and inhibition potency make it indispensable for advanced cancer and immunopathological research.

• AP20187: Precision Chemical Inducer of Dimerization in Gene

  2026-07-29

  AP20187 enables unparalleled control in conditional gene therapy and regulated cell therapy by orchestrating fusion protein dimerization with high specificity. This article details experimental workflows, troubleshooting strategies, and the translational impact of AP20187—highlighting its role in programmable protein signaling and metabolic research.

• Phos binding reagent (Phosbind) acrylamide: Reliable SDS-PAG

  2026-07-28

  This article explores practical laboratory challenges in protein phosphorylation analysis and demonstrates how Phos binding reagent (Phosbind) acrylamide (SKU F4002) streamlines SDS-PAGE–based detection workflows. Scenario-driven Q&A covers conceptual, protocol, and vendor selection pain points, offering evidence-based guidance for researchers seeking robust, antibody-free phosphorylation detection.

• NP-40 Lysis Buffer: Non-Denaturing Extraction for Protein An

  2026-07-28

  NP-40 Lysis Buffer is a non-denaturing lysis buffer optimized for extracting native proteins from a wide range of cell types. Its mild formulation preserves protein-protein interactions, enabling rigorous neuroimmunology and cell signaling studies. This article details its composition, mechanism, and evidence base for reproducible protein extraction.

• DNase I (RNase-free): Mechanistic Insights and New Frontiers

  2026-07-27

  Explore the advanced mechanism and emerging applications of DNase I (RNase-free) in molecular biology. This article provides a unique, evidence-based perspective on ribonuclease-free DNase I, integrating recent neurobiological findings to guide innovative assay design.

• Pterostilbene Promotes Mitophagy to Counter Dermal Fibroblas

  2026-07-27

  Zhou et al. (2025) reveal that pterostilbene delays senescence in human dermal fibroblasts by enhancing mitophagy and mitochondrial function, addressing both intrinsic and extrinsic skin aging. These findings underscore mitochondrial quality control as a promising therapeutic target for skin aging interventions.

• VE-822 ATR Inhibitor: Advanced Workflows for DNA Damage Resp

  2026-07-26

  VE-822, a potent ATR inhibitor, transforms DNA damage response research by enabling precise sensitization of pancreatic cancer models to chemoradiotherapy. This guide details actionable workflows, integration with iPSC-based platforms, and expert troubleshooting to maximize experimental reproducibility and translational impact.

• Kanamycin Sulfate: Water-Soluble Antibiotic for RNA Purifica

  2026-07-25

  Kanamycin Sulfate stands out as a high-purity, water-soluble antibiotic essential for robust cell selection and advanced RNA workflows. Recent studies reveal its pivotal role in maintaining selective pressure and purity during circular RNA production, setting APExBIO’s formulation apart for both reliability and reproducibility.

• UK-5099: Precision Modulation of Mitochondrial Metabolism in

  2026-07-24

  This article delivers a thought-leadership perspective on leveraging UK-5099 (PF-1005023) as a selective mitochondrial pyruvate carrier inhibitor, guiding translational researchers through mechanistic insights, standardized experimental parameters, and the evolving landscape of immunometabolic assay design. Drawing on recent advances in whole-blood stimulation protocols and cross-referencing the latest domain literature, we map the strategic role of UK-5099 in decoding metabolic-immune crosstalk, positioning APExBIO’s offering as a trusted solution for reproducibility and translational impact.

446 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page